Common tuberculosis vaccine can be used to prevent infection as well as disease

August 5, 2014

The vaccine used to protect against tuberculosis disease (bacillus calmette-guerin or BCG) also protects against tuberculosis infection (mycobacterium) as well as protecting against progression from infection to disease, finds a paper published in the BMJ today.

The BCG vaccine has been subject to numerous trials and studies over several decades, which have shown that it has a 60-80% protective efficacy against severe forms of tuberculosis (TB) in children.

But there is a lack of evidence on whether the vaccine is effective against TB infection. The authors say if BCG is found to protect against infection it will have key implications for the use of BCG in current immunisation programmes, as well as in the future development of new improved TB vaccines.

Researchers from the UK assessed the evidence as to whether BCG protects against infection as well as disease.

Data from studies was taken from Embase, Medline and the Cochrane Library from 1950 – 2013. All patients were under 16 years of age and studies included both BCG vaccinated and unvaccinated children.

Primary analysis focused on whether the BCG vaccine administered prior to exposure was associated with no infection in children who had contact with infectious TB.

The analysis included studies of children who were screened as part of a TB outbreak investigation, referred to hospital as close contacts of those with TB, household contacts of an infectious adult or contacts in other settings. Four studies were from the UK, two each in The Gambia and Spain and one each in Greece, Italy, Indonesia, Turkey, South Africa and Cambodia. BCG vaccination was assessed by BCG scar, confirmed medical records or parental recall.

There were 3855 participants in total, with an overall risk ratio of 19% effectiveness of the BCG vaccine against , among vaccinated children after exposure, compared with unvaccinated children.

Interestingly, studies conducted above 40° latitude (UK, Spain, Greece, Italy, Turkey) showed a 26% effectiveness while studies at lower latitudes 20-40° (The Gambia, Indonesia, South Africa and Cambodia) and 20-0° latitude showed no evidence of protective effect.

In conclusion, lead researcher Ibrahim Abubakar from University College London, says that the effect of the BCG vaccination would be different for high versus low tuberculosis incidence countries. They add that due to countries with a policy of vaccination at birth tending to have higher incidence of TB, the "use of BCG is sensible". They recommend that future trials need to investigate the efficacy of the new against .

Explore further: BCG vaccine more effective than previously thought

More information: Effect of BCG vaccination against Mycobacterium tuberculosis infection in children: systematic review and meta-analysis, BMJ, 2014.

Related Stories

BCG vaccine more effective than previously thought

December 19, 2013
The BCG vaccine has been found to be more effective against the most common form of tuberculosis than previously thought, according to a new study in Clinical Infectious Diseases.

New tuberculosis vaccine boosts impacts of old counterpart

October 2, 2013
A tuberculosis vaccine developed at McMaster University offers new hopes for the global fight against tuberculosis.

Incidence of childhood tuberculosis could be 25 percent higher than previous estimates

July 8, 2014
New estimates indicate that over 650 000 children develop tuberculosis (TB) every year in the 22 countries with a high burden of the disease (HBCs)*—almost 25% higher than the total number of new cases worldwide estimated ...

Better vaccines for tuberculosis could save millions of lives

August 28, 2012
Cases of one of the world's deadliest diseases—tuberculosis—are rising at an alarming rate, despite widespread vaccination. Reasons for the ineffectiveness of the vaccine, especially in regions where this infectious disease ...

Recommended for you

Finish your antibiotics course? Maybe not, experts say

July 27, 2017
British disease experts on Thursday suggested doing away with the "incorrect" advice to always finish a course of antibiotics, saying the approach was fuelling the spread of drug resistance.

Co-infection with two common gut pathogens worsens malnutrition in mice

July 27, 2017
Two gut pathogens commonly found in malnourished children combine to worsen malnutrition and impair growth in laboratory mice, according to new research published in PLOS Pathogens.

Phase 3 trial confirms superiority of tocilizumab to steroids for giant cell arteritis

July 26, 2017
A phase 3 clinical trial has confirmed that regular treatment with tocilizumab, an inhibitor of interleukin-6, successfully reduced both symptoms of and the need for high-dose steroid treatment for giant cell arteritis, the ...

A large-scale 'germ trap' solution for hospitals

July 26, 2017
When an infectious airborne illness strikes, some hospitals use negative pressure rooms to isolate and treat patients. These rooms use ventilation controls to keep germ-filled air contained rather than letting it circulate ...

Researchers report new system to study chronic hepatitis B

July 25, 2017
Scientists from Princeton University's Department of Molecular Biology have successfully tested a cell-culture system that will allow researchers to perform laboratory-based studies of long-term hepatitis B virus (HBV) infections. ...

Male hepatitis B patients suffer worse liver ailments, regardless of lifestyle

July 25, 2017
Why men with hepatitis B remain more than twice as likely to develop severe liver disease than women remains a mystery, even after a study led by a recent Drexel University graduate took lifestyle choices and environments ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.